Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor

Blood

Volumn 107, Issue 1, 2006, Pages 135-142

  Qi, Jian C ^b   Wang, Jing ^b   Mandadi, Sravan ^b   Tanaka, Kumiko ^b   Roufogalis, Basil D ^b   Madigan, Michele C ^b   Lai, Kenneth ^b   Yan, Feng ^b   Chong, Beng H ^b   Stevens, Richard L ^b   Krilis, Steven A ^a  

^a ST GEORGE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CD4 ANTIGEN; CD9 ANTIGEN; INOSITOL TRISPHOSPHATE; INTERLEUKIN 16; MONOCLONAL ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; TETRASPANIN; WORTMANNIN; XESTOSPONGIN C;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CELL ACTIVATION; CELL MEMBRANE; CHEMOTAXIS; CHO CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MAST CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 30144435055     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-03-1312     Document Type: Article

References (52)

1. Cruikshank WW, Kornfeld H, Center DM. Interleukin 16. J Leukoc Biol. 2000;67:757-766.
2. Center DM, Cruikshank W. Modulation of lymphocyte migration by human lymphokines: I, identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol. 1982;128:2563-2568.
3. Cruikshank W, Center DM. Modulation of lymphocyte migration by human lymphokines: II, purification of a lymphotactic factor (LCF). J Immunol. 1982;128:2569-2574.
4. Qi JC, Stevens RL, Wadley R, et al. IL-16 regulation of human mast cells/basophils and their susceptibility to HIV-1. J Immunol. 2002;168:4127-4134.
5. Rand TH, Cruikshank WW, Center DM, Weller PF. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med. 1991;173:1521-1528.
6. + T lymphocytes and monocytes. J Immunol. 1987;138:3817-3823.
7. Kaser A, Dunzendorfer S, Offner FA, et al. A role for IL-16 in the cross-talk between dendritic cells and T cells. J Immunol. 1999;163:3232-3238.
8. Cruikshank WW, Greenstein JL, Theodore AC, Center DM. Lymphocyte chemoattractant factor induces CD4-dependent intra-cytoplasmic signaling in lymphocytes. J Immunol. 1991;146:2928-2934.
9. + T cells by IL-16 and IL-2. J Immunol. 1998;160:2115-2120.
10. 4 and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J Immunol. 2002;168:4756-4763.
11. + cells transfected with an IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat Med. 1997;3:659-664.
12. Maciaszek JW, Parada NA, Cruikshank WW, et al. IL-16 represses HIV-1 promoter activity. J Immunol. 1997;158:5-8.
13. Truong MJ, Darcissac EC, Hermann E, et al. Interleukin-16 inhibits human immunodeficiency virus type 1 entry and replication in macrophages and in dendritic cells. J Virol. 1999;73:7008-7013.
14. Amiel C, Darcissac E, Truong MJ, et al. Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression. J Infect Dis. 1999;179:83-91.
15. Baier M, Werner A, Bannert N, Metzner K, Kurth R. HIV suppression by interleukin-16 [letter]. Nature. 1995;378:563.
16. Cruikshank WW, Center DM, Nisar N, et al. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci U S A. 1994;91:5109-5113.
17. Baier M, Bannert N, Werner A, Lang K, Kurth R. Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci U S A. 1997;94:5273-5277.
18. Zhang Y, Center DM, Wu DM, et al. Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem. 1998;273:1144-1149.
19. Wilson KC, Cruikshank WW, Center DM, Zhang Y. Prointerleukin-16 contains a functional CcN motif that regulates nuclear localization. Biochemistry. 2002;41:14306-14312.
20. + T lymphocytes in rheumatoid arthritis. Eur J Immunol. 1998;28:2661-2671.
21. + T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol. 1998;102:645-650.
22. Mathy NL, Bannert N, Norley SG, Kurth R. CD4 is not required for the functional activity of IL-16. J Immunol. 2000;164:4429-4432.
23. Stoitzner P, Ratzinger G, Koch F, et al. Interleukin 16 supports the migration of Langerhans cells, partly in a CD4-independent way. J Invest Dermatol. 2001;116:641-649.
24. Boucheix C, Rubinstein E. Tetraspanins. Cell Mol Life Sci. 2001;58:1189-1205.
25. Valent P, Ashman LK, Hinterberger W, et al. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood. 1989;73:1778-1785.
26. Guo CB, Kagey-Sobotka A, Lichtenstein LM, Bochner BS. Immunophenotyping and functional analysis of purified human uterine mast cells. Blood. 1992;79:708-712.
27. Nilsson G, Forsberg K, Bodger MP, et al. Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells. Immunology. 1993;79:325-330.
28. Baghestanian M, Bankl H, Sillaber C, et al. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone. Leukemia. 1996;10:159-166.
29. Saito H, Nakajima T, Matsumoto K. Human mast cell transcriptome project. Int Arch Allergy Immunol. 2001;125:1-8.
30. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science. 1998;282:938-941.
31. Imai T, Yoshie O. C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells. J Immunol. 1993;151:6470-6481.
32. Toyo-Oka K, Yashiro-Ohtani Y, Park CS, et al. Association of a tetraspanin CD9 with CD5 on the T cell surface: role of particular transmembrane domains in the association. Int Immunol. 1999;11:2043-2052.
33. Miyake M, Koyama M, Seno M, Ikeyama S. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med. 1991;174:1347-1354.
34. Boucheix C, Benoit P, Frachet P, et al. Molecular cloning of the CD9 antigen: a new family of cell surface proteins. J Biol Chem. 1991;266:117-122.
35. Razin E, Ihle JN, Seldin D, et al. Interleukin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol. 1984;132:1479-1486.
36. Li L, Macpherson JJ, Adelstein S, et al. Conditioned medium from a cell strain derived from a patient with mastocytosis induces preferential development of cells that possess high-affinity IgE receptors and the granule protease phenotype of mature cutaneous mast cells. J Biol Chem. 1995;270:2258-2263.
37. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res. 1988;12:345-355.
38. Waterhouse R, Ha C, Dveksler GS. Murine CD9 is the receptor for pregnancy-specific glycoprotein 17. J Exp Med. 2002;195:277-282.
39. Rudert F, Saunders AM, Rebstock S, Thompson JA, Zimmermann W. Characterization of murine carcinoembryonic antigen gene family members. Mamm Genome. 1992;3:262-273.
40. lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration. J Biol Chem. 1995;270:17081-17086.
41. Parada NA, Cruikshank WW, Danis HL, Ryan TC, Center DM. IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C. Cell Immunol. 1996;168:100-106.
42. Franke TF, Kaplan DR, Cantley LC, Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 1997;275:665-668.
43. Stokoe D, Stephens LR, Copeland T, et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science. 1997;277:567-570.
44. Rameh LE, Rhee SG, Spokes K, et al. Phosphoinositide 3-kinase regulates phospholipase C-mediated calcium signaling. J Biol Chem. 1998;273:23750-23757.
45. Rhee SG, Choi KD. Regulation of inositol phospholipid-specific phospholipase C isozymes. J Biol Chem. 1992;267:12393-12396.
46. Brenner B, Koppenhoefer U, Lepple-Wienhues A, et al. The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation. Biochem Biophys Res Commun. 1997;239:11-17.
47. Bonser RW, Thompson NT, Randall RW, et al. Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil. Br J Pharmacol. 1991;103:1237-1241.
48. Nakanishi S, Catt KJ, Balla T. Inhibition of agonist-stimulated inositol 1,4,5-trisphosphate production and calcium signaling by the myosin light chain kinase inhibitor, wortmannin. J Biol Chem. 1994;269:6528-6535.
49. Barker SA, Caldwell KK, Hall A, et al. Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by FcεR1 cross-linking. Mol Biol Cell. 1995;6:1145-1158.
50. 2+-signalling induced by Fc receptor cross-linking in human neutrophils. Biochem J. 1997;323:87-94.
51. Fleming TJ, Donnadieu E, Song CH, et al. Negative regulation of FcεRI-mediated degranulation by CD81. J Exp Med. 1997;186:1307-1314.
52. Kraft S, Fleming T, Billingsley JM, et al. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. J Exp Med. 2005;201:385-396.